Neurocognitive Disorders Clinical Trials

16 recruiting

Frequently Asked Questions

Common questions about Neurocognitive Disorders clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 119 of 19 trials

Recruiting

Early Detection of Alzheimer's Disease and Affective Disorders by Automated Voice and Speech Analysis (PLATA)

Neurocognitive Disorders
Centre Hospitalier Universitaire de Nice100 enrolled1 locationNCT05943834
Recruiting
Phase 3

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting

Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders

Cognitive Impairment, MildApathy in DementiaApathy+2 more
KompanionCare SAS80 enrolled5 locationsNCT07237009
Recruiting
Not Applicable

Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia

DementiaAlzheimer DiseaseCommunication Disorders+11 more
University of Texas at Austin60 enrolled3 locationsNCT05741853
Recruiting

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

Cognitive ImpairmentDementiaCognitive Dysfunction+7 more
Mclean Hospital40 enrolled1 locationNCT05245903
Recruiting
Not Applicable

Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia

DementiaBrain DiseasesCentral Nervous System Diseases+5 more
Advanced Technology & Communications158 enrolled11 locationsNCT06088121
Recruiting

Evaluation of the Link Between Carotid Arterial Wall Viscosity and Major Neurocognitive Disorders

Neurocognitive DisordersAlzheimer's Disease
University Hospital, Rouen140 enrolled1 locationNCT07205003
Recruiting

Biobank and Brain Health in Bordeaux.

DementiaBrain DiseasesDepression+12 more
University Hospital, Bordeaux2,050 enrolled1 locationNCT05322343
Recruiting
Not Applicable

rTMS for Apathy Clinical Trial

DementiaAlzheimer DiseaseMild Cognitive Impairment+3 more
Sunnybrook Health Sciences Centre10 enrolled1 locationNCT05561205
Recruiting
Not Applicable

Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

Patient SatisfactionAlzheimer DiseaseCaregiver Burden+7 more
University of Michigan3,000 enrolled7 locationsNCT05929703
Recruiting

CONCEPTT Kids International Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes

Neurocognitive Disorders
University of Manitoba225 enrolled3 locationsNCT05754567
Recruiting
Not Applicable

B.R.A.I.N in People Living With HIV Study

HIV-associated Neurocognitive Disorders
University of Cape Town43 enrolled3 locationsNCT06466642
Recruiting

Safe Brain Initiative, Operationalizing Precision Anaesthesia

PainStressAnxiety+14 more
University of Southern Denmark15,000 enrolled1 locationNCT05765162
Recruiting

Effect of Gastrectomy on Gut Microbiome and Cognitive Function

Gastric CancerPerioperative Neurocognitive Disorders
Jiangjiang Bi45 enrolled1 locationNCT06186089
Recruiting

DRIVing Simulator and People With NeuroCognitive Disorders

Neurocognitive Disorders
University Gustave Eiffel150 enrolled1 locationNCT06320639
Recruiting

Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease

Dementia AlzheimersMild Cognitive ImpairmentNeurocognitive Disorders+1 more
University Hospital, Basel, Switzerland100 enrolled1 locationNCT03672279
Recruiting
Not Applicable

COGNIFOOD-Changing the Carbohydrate/Fat-ratio to Prevent Cognitive Decline and Alzheimer Pathology: A Pilot Study

Alzheimer DiseaseMild Cognitive ImpairmentNeurocognitive Disorders+1 more
Karolinska University Hospital40 enrolled1 locationNCT06105320
Recruiting
Not Applicable

A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China

Cognitive ImpairmentBrain DiseasesCentral Nervous System Diseases+7 more
Zhejiang University1,200 enrolled1 locationNCT05886114
Recruiting

Shanghai At Risk for Alzheimer's Disease: a Cohort Study

Cognitive ImpairmentDementiaAlzheimer Disease+2 more
Ruijin Hospital3,418 enrolled1 locationNCT05597410